We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

41 hedge funds and large institutions have $41.6M invested in Axsome Therapeutics in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

133% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 6

32.21% more ownership

Funds ownership: 0% → 32.21% (+32%)

14% more funds holding

Funds holding: 36 → 41 (+5)

16% less capital invested

Capital invested by funds: $49.4M → $41.6M (-$7.8M)

Holders
41
Holders Change
+5
Holders Change %
+13.89%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$596K
2
BFA
BlackRock Fund Advisors
California
+$399K
3
Morgan Stanley
Morgan Stanley
New York
+$199K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$130K
5
BIT
BlackRock Institutional Trust
California
+$89.1K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.19M
2
LOAMU
Lombard Odier Asset Management (USA)
New York
-$548K
3
Citadel Advisors
Citadel Advisors
Florida
-$104K
4
BA
BlackRock Advisors
Delaware
-$4.35K
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$3.74K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$15.9M -$2.19M -311,760 -12%
JP Morgan Chase
2
JP Morgan Chase
New York
$10.8M +$79.9K +11,383 +0.7%
Stifel Financial
3
Stifel Financial
Missouri
$2.8M – – –
BFA
4
BlackRock Fund Advisors
California
$2.42M +$399K +56,848 +19%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.84M +$130K +18,440 +7%
LOAMU
6
Lombard Odier Asset Management (USA)
New York
$1.69M -$548K -78,061 -24%
State Street
7
State Street
Massachusetts
$908K +$59.5K +8,466 +7%
Allianz Asset Management
8
Allianz Asset Management
Germany
$743K – – –
Northern Trust
9
Northern Trust
Illinois
$711K +$1.94K +276 +0.3%
Millennium Management
10
Millennium Management
New York
$572K +$596K +84,805 New
BIT
11
BlackRock Institutional Trust
California
$464K +$89.1K +12,687 +23%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$355K +$24.7K +3,517 +7%
Morgan Stanley
13
Morgan Stanley
New York
$338K +$199K +28,327 +130%
Mariner
14
Mariner
Kansas
$304K – – –
BIM
15
BlackRock Investment Management
Delaware
$256K – – –
TCIM
16
TIAA CREF Investment Management
New York
$242K +$21.3K +3,038 +9%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$208K +$67.2K +9,564 +45%
California State Teachers Retirement System (CalSTRS)
18
California State Teachers Retirement System (CalSTRS)
California
$155K -$2.11K -300 -1%
BWP
19
Baldwin Wealth Partners
Massachusetts
$133K +$31.6K +4,500 +30%
Charles Schwab
20
Charles Schwab
California
$120K – – –
TA
21
Teachers Advisors
New York
$115K – – –
JMFC
22
J.M. Forbes & Co
Massachusetts
$101K – – –
SSB
23
Sandy Spring Bank
Maryland
$59K +$61.5K +8,755 New
New York State Common Retirement Fund
24
New York State Common Retirement Fund
New York
$57K – – –
Deutsche Bank
25
Deutsche Bank
Germany
$47K +$37.1K +5,279 +289%
1
2

AXSM Hedge Fund Activity: Q4 2016 in Review

41 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q4 2016, worth a combined $41.6M — down 16% from $49.4M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new AXSM positions and 1 closed out — a net gain of 5 holders — while 14 added to existing stakes and 6 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $596K. The largest seller was Fidelity Investments, cutting an estimated $2.19M.

  • 41 institutional investors held Axsome Therapeutics (AXSM) as of Q4 2016, up from 36 in Q3 2016.
  • Funds reported $41.6M of Axsome Therapeutics stock for Q4 2016, down 16% quarter-over-quarter.
  • 6 funds opened new Axsome Therapeutics positions in Q4 2016 and 1 closed out, a net change of +5 holders.
  • The largest Axsome Therapeutics buyer in Q4 2016 was Millennium Management, an estimated $596K added.
  • The largest Axsome Therapeutics seller in Q4 2016 was Fidelity Investments, an estimated $2.19M sold.

Based on aggregated 13F filings for Q4 2016.